Statistics

Total Visits

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive66

Select a period of time:

Number of views in the range

Views
Preliminary safety results of regorafenib (REG) as a single agent for first-line treatment of frail and/or unfit for polychemotherapy patients (pts) with metastatic colorectal cancer (mCRC): A phase II study of the Spanish Cooperative Group for Digestive4

Views

Views
September 20252
October 20251
November 20251
December 20250
January 20260
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil2
Argentina1
United States1
 

Top cities views

Views
Corrientes1
Dallas1
São Paulo1
Uberaba1